Dr. Frederik Buijs is a senior medical director at Roche Pharma. He holds a PhD in neuroscience and has an MD specializing in neurology. He has worked in healthtech developing real world data studies and data platforms, to accelerate peri-launch evidence generation strategies. At Roche he has further led initiatives leveraging federated and GenAI approaches to enable and scale data-driven research across the Neuroscience portfolio. He currently leads initiatives in MS on biomarker development to de-risk clinical trials and e2e evidence generation integrating early and late stage to maximise pipeline value and launch readiness.